Nebraska Methodist Hospital is a clinical research site located in Omaha, Nebraska, United States 68114.
Crixeo Clinical Trials Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.
Nebraska Methodist Hospital has participated in 355 clinical trials with 140 currently active.
Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.
Sponsors: ECOG-ACRIN Cancer Research Group, Pfizer, National Cancer Institute (NCI).
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Nebraska · View every site in Omaha
Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Nebraska Methodist Hospital has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Nebraska Methodist Hospital has 355 clinical trials on record, with 140 currently active. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.
Nebraska Methodist Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.